Dynavax Technologies (DVAX) Stock Rating Reaffirmed by Royal Bank of Canada

Ruben Hill
March 9, 2018

It now has negative earnings. Clearbridge LLC purchased a new stake in shares of Dynavax Technologies during the fourth quarter worth about $10,335,000. Dynavax Technologies Corp now has $1.07B valuation.

Shares of Dynavax Technologies closed the previous trading session at 17.60 down -0.40 2.22% with 17.200000762939453 shares trading hands. About 1.02 million shares traded. Dynavax Technologies Corporation (NASDAQ:DVAX) has declined 63.84% since March 8, 2017 and is downtrending. It has underperformed by 80.54% the S&P500.

Since January 1, 0001, it had 1 insider purchase, and 0 sales for $387,902 activity. Over the past five trading sessions it is 12.15%; -0.28% for the month; 3.45% for the last quarter; -5.51% for the past six-months; and 207.69% for the last 12 months. The ONE Group Hospitality, Inc. It is down 0.00% since March 8, 2017 and is. It has underperformed by 16.70% the S&P500.

Want to see what other hedge funds are holding DVAX? Taconic Capital Advisors Lp owns 306,000 shares or 0.43% of their U.S. portfolio. Bnp Paribas Arbitrage has 6,139 shares.

Rhenman & Partners Asset Management Ab increased Nektar Therapeutics (NASDAQ:NKTR) stake by 71,194 shares to 866,194 valued at $20.79M in 2017Q3. The number of shares now owned by investors are 376.42 mln.

Investors sentiment decreased to 1 in 2017 Q3. Its down 0.27, from 2.33 in 2017Q2. It dived, as 13 investors sold Dynavax Technologies Corporation shares while 19 reduced holdings. 25 funds opened positions while 41 raised stakes. The count of Hold ratings in that period was 0. Ameriprise Financial owns 597,990 shares or 0.01% of their USA portfolio. Alliancebernstein Lp reported 131,290 shares. ULTA's SI was 3.25M shares in March as released by FINRA. Northern Corporation owns 0% invested in Dynavax Technologies Corporation (NASDAQ:DVAX) for 688,490 shares. Voya Inv Ltd Com reported 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX). EAM Investors LLC purchased a new stake in shares of Dynavax Technologies during the third quarter worth about $5,116,000. Pnc Fincl Serv Gp has invested 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX). Falcon Point Cap Ltd accumulated 36,870 shares or 0.12% of the stock.

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Pennsylvania-based Susquehanna Intl Grp Ltd Liability Partnership has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Royal Bank of Canada increased its holdings in shares of Dynavax Technologies by 17.0% in the second quarter. Therefore 67% are positive.

DVAX has been the topic of several analyst reports. BidaskClub cut shares of Dynavax Technologies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 6th. Finally, JPMorgan Chase & Co. cut shares of Dynavax Technologies from an "overweight" rating to a "neutral" rating and lowered their price objective for the stock from $31.00 to $25.00 in a research report on Wednesday, February 14th. The firm has "Buy" rating by RBC Capital Markets given on Sunday, October 29. Deutsche National Bank Ag has invested 0.02% in Dynavax Technologies Corporation (NASDAQ:DVAX). Cantor Fitzgerald lifted their price objective on Dynavax Technologies from $24.00 to $25.00 and gave the stock an "overweight" rating in a report on Thursday, November 9th. On Monday, January 22 the stock rating was upgraded by RBC Capital Markets to "Buy". The rating was maintained by William Blair with "Buy" on Monday, August 7. The firm earned "Hold" rating on Wednesday, July 26 by RBC Capital Markets. William Blair has "Buy" rating and $3000 target.

Since December 13, 2017, it had 0 insider buys, and 2 sales for $199,261 activity.

In related news, VP David Louis Johnson sold 3,092 shares of the business's stock in a transaction dated Thursday, January 4th.

On 12/13/2017 Robert Coffman, Insider, sold 7,500 with an average share price of $18.90 per share and the total transaction amounting to $141,750.00.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article